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Hemodynamic monitoring has become a real challenge in the intensive care unit. As an integrative parameter for oxygen
supply/demand, venous oxygen saturation (SvO2) provided by pulmonary artery catheterization is one of the most popular
parameters to assess the adequacy of cardiac output. However, technical limitations and potential iatrogenic complications
constitute important limits for a widespread use. Regular central venous catheters coupled with a fiberoptic lumen for central
venous oxygen saturation (ScvO2) monitoring have been proposed as a surrogate for SvO2 monitoring. The purpose of the present
article is to review the physiological backgrounds of circulation, the pathophysiology of circulatory failure and subsequent venous
oxygen saturation alterations, and finally the merits and the limits of the use of ScvO2 in different clinical situations.
1. Introduction
Hemodynamic monitoring has become a common practice
in the intensive care unit. Besides blood pressure measure-
ment, most industrial efforts have concentrated on providing
devices for cardiac output monitoring. However, adequate
adaptation of thesemacrohemodynamic parameters is some-
how challenging. Indeed, as cardiac output is an adaptive
parameter, it is always difficult to judge whether a given
value at a given time for a given patient is appropriate or
not. Similarly, which value should be considered an ap-
propriate goal for blood pressure, considering regional
perfusion specificities (e.g., autoregulation or flow/pressure
dependency), patient’s age, history of hypertension, and so
on. Therefore, considering that O2 supply to the tissue is the
basic objective, intensivists have been trying to find out an
integrative parameter that would be more suitable to globally
assess hemodynamic status of their patients. As a surrogate
for evaluating O2 demand/supply adequacy, central oxygen
venous saturation (ScvO2) has become a popular parameter.
As explained for the dummies, oxygen venous saturation is
interpreted as a bank statement at the end of the month: “if
the balance is negative, you can consider two explanations:
you spend too much money or you earn not enough.” The
aim of the present paper is precisely to critically analyze the
physiological basements for such an interpretation, the data
that support its use in clinical practice, and finally the limits
that should be kept in mind while using such a parameter at
the bedside.
2. Physiological Background
2.1. Normal Circulation Physiology. One of the main goals of
blood circulation is to ensure oxygen supply to organs and
tissues. The determinants of arterial oxygen delivery (DO2)
are
(i) cardiac output (CO);
(ii) arterial content in oxygen (CaO2).
The arterial content in oxygen has 2 components.
(1) The main component is oxygen bound to hemo-
globin (Hb).
(2) The secondary component is dissolved oxygen.
The first one depends on hemoglobin concentration,
hemoglobin affinity for oxygen (which varies for Hb isotypes
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and with environmental conditions such as temperature, pH,
or 2.3DPG concentrations), and, therefore, Hb oxygen sat-
uration. The second component depends on arterial partial
pressure of oxygen (PaO2) and is considered as negligible
because of the very solubility coefficient of oxygen in plasma.
It is then possible to set the equations:
(i) CaO2 = (Hb × 1.34 × SaO2) + (0.003 × PaO2),
(ii) DO2 = CO × CaO2.
By ignoring the dissolved oxygen component, we get
(i) DO2 = CO × 1,34 × SaO2.
Arterial blood is then deoxygenated in tissues. Tissue
oxygen extraction depends on their demand but also on their
ability for oxygen extraction. Therefore, after peripheral oxy-
gen extraction, venous oxygen content depends on arterial
content and tissue oxygen extraction.
2.2. Pathophysiology of Circulatory Failure. Shock is one of
the leading causes of admission in the intensive care unit.
It is usually defined as a mean arterial pressure (MAP)
<60mmHg or a systolic arterial pressure (SAP) <90mmHh,
or a decrease in SAP greater than 40mmHg as compared
to the usual SAP [1]. For many years, hemodynamic man-
agement has focused on “macrocirculatory” parameters such
as blood pressure or cardiac output. Though the magnitude
of macrocirculatory disorders is well known to be related
to prognosis [2], its optimization seems mandatory [3] but
insufficient [4]. Indeed, in septic shock patients, Sakr et al.
observed that after 24 h hours of intensive care, the values of
MAP, cardiac index (CI), and central venous pressure (CVP)
did not discriminate survivors from nonsurvivors.
Hence, shock can be defined as a macrohemodynamic
instability leading to an inappropriate oxygen supply/
demand balance. Schematically, as represented in Figure 1,
any fall in DO2 is initially compensated by an increase in
tissue oxygen extraction (EO2), explaining that tissue VO2 is
initially maintained. However, when tissue oxygen extraction
capacity is overtaken, oxygen consumption begins to fall and
lactate concentration increases, indicating a switch of the
cellular metabolism from aerobic glycolysis to cytoplasmic
anaerobic glycolysis. This threshold immediately precedes
the onset of clinical organ failures.
Considering such a pathophysiological scheme, hemo-
dynamic support in shock should aim at correcting macro-
circulatory but also microcirculatory parameters in order to
avoid any local fall in O2 supply below this crucial threshold.
Therefore, a parameter such as venous oxygen saturation
(SvO2), that should reflect the inadequacy in oxygen supply,
might be of great help.
2.3. Physiological Determinants for Venous Oxygen Saturation.
Oxygen extraction in the tissues can be mathematically
defined as follows:
(i) EO2 = CO × (CaO2− CvO2),
(ii) EO2 = VO2/DO2,
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Figure 1: Evolution of oxygen consumption when oxygen delivery
decreases. From Vincent and De Backer [5] with permission.
Note the presence of a DO2 threshold located at approximately
100mL/min. Below this value, oxygen consumption begins to fall
and lactate concentration increases, indicating a switch from aer-
obic to anaerobic metabolism.
with CvO2 being venous oxygen content and VO2 being
oxygen consumption.
Then, venous oxygen saturation can then be calculated using
the following formula:
(i) SvO2 = SaO2− (VO2/(CO × Hb × 1.34)).
Hence, any decrease in venous oxygen saturation should be
explained by
(i) a decrease in SaO2;
(ii) a decrease in cardiac output;
(iii) a decrease in hemoglobin level;
(iv) an increase of oxygen consumption (VO2).
Thus, providing that SaO2, oxygen consumption, and
haemoglobin level are in normal ranges, SvO2 can be used
as a surrogate for cardiac output.
Likewise, if
(i) EO2 = CO × (CaO2− CvO2),
(ii) EO2 = VO2/DO2,
then,
(i) EO2 = (SaO2− SvO2)/SaO2.
Consequently, when SaO2 = 100%, then EO2 = 1− SvO2 and
SvO2 = 1 − EO2.
Then, SvO2 is also a good surrogate for EO2.
In shock, decrease in tissue oxygen supply is mostly
related to a decrease in tissue blood flow, would it be
relative (as in distributive shocks) or real (as in hemorrhagic
shock). The first recommended measure in international
guidelines for shock resuscitation consists in optimizing
cardiac output by repeated fluid challenges [6], in order
to correct oxygen supply/demand imbalance. In this aspect,
SvO2 measurements could help guiding fluid challenges in
shock patients.
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3. SvO2—ScvO2: Is It the Same?
The reference technique to assess the adequacy of oxygen
supply is the mixed venous oxygen saturation (SvO2),
provided by pulmonary artery catheter (a.k.a. Swan-Ganz
catheter) [7]. However, limitations related to difficulties of
insertion and placement, but also to potential complications
related with such a catheter, lead to a substantial decrease
in its use. In the meantime, industrials have developed
regular central venous catheter coupled with a fiberoptic
lumen for continuous haemoglobin saturation monitoring.
Placed through a jugular of a subclavian vein, at the
confluent of the superior vena cava and the right auricle,
such catheters actually monitor the central venous oxygen
saturation (ScvO2) [8].
However, one should ask whether SvO2 and ScvO2
provide the same information. Actually, taken in pulmonary
artery, SvO2 is a surrogate for global tissue oxygenation,
whereas ScvO2 essentially reflects the oxygenation of the
upper part of the body (head, neck upper limbs, and upper
part of the trunk) and of a lower proportion of the lower
part of the body (lower part of the trunk and lower limbs),
depending on the exact position of the catheter’s extremity.
Anyhow, ScvO2 does not include venous blood coming
from coronary sinus commonly located in the right auricle.
Thus, taken at the confluent of the vena cava in the right
auricle (i.e., upstream from the coronary sinus), ScvO2 does
not include myocardial oxygenation. On the contrary, SvO2
concerns venous blood from pulmonary artery, that is, by
definition, after the coronary venous sinus. Such a difference
might highly impact the observed values, given that (1)
venous blood from the coronary sinus, with a saturation
of oxygen close to 40%, is the most deoxygenated venous
blood of the body [9] and (2) that in critically ill patients,
myocardial oxygen supply/demand imbalance is likely to
occur.
4. ScvO2: A ValidatedMonitoring Parameter
4.1. Experimental Validation. Many studies have compared
the ScvO2 and SvO2 values in the same patients (Table 1).
Most of them showed a good correlation between ScvO2 and
SvO2 and a similar trend in the temporal evolution. In 1989,
Reinhart et al. [10] reported, in a dog model, a correlation
coefficient between ScvO2 and SvO2of 0.96. In this study, the
two values exhibited less than 5% difference in 77% of the
cases. Later on, Reinhart et al. [11] confirmed their results
in ICU patients: ScvO2 and SvO2 had similar evolution
in 90% of the cases and had a correlation coefficient of
0.81 (P < 0.001). Similarly, Martin et al. [12] reported a
parallel evolution of ScvO2 and SvO2 in 75% of the cases.
Considering such results, it seems that ScvO2 and especially
its evolution over time could be used as an interesting
surrogate for SvO2 monitoring. However, the impact of
ScvO2 monitoring on the prognosis of critically ill patients
remained to be demonstrated.
4.2. Clinical Validation. Some authors, therefore, focused on
evaluating the connection between SvcO2 and prognosis and
especially the benefits turnoff considering SvcO2 optimiza-
tion as a goal for resuscitation. Pearse et al. [23] observed
in a cohort of 118 postoperative patients from major
surgery that a decrease in ScvO2 during the first 8 hours
was associated with an increase in 28-day morbidity and
mortality. Consistently, Futier et al. [24] showed in major
abdominal surgery that a ScvO2 <70% was associated with
postoperative complications. In addition, ScvO2 seems to
be a reliable and sensitive parameter to detect hemorrhage
in trauma patients admitted to the Emergency Room [25],
while other series suggest that ScvO2 could be a prognosis
marker in myocardial infarction [26], acute heart failure
[27], as well as in severe sepsis patients [28].
But the great clinical advantage related to early ScvO2has
been suggested by Rivers et al. [29]. Indeed, these authors
reported that, in severe sepsis patients, an early and aggres-
sive therapy that aimed at normalizing in the first hours the
values of ScvO2 MAP and CVP achieved a reduction in in-
hospital mortality from 46.5% to 30.5% (relative risk 0.58
(0.38–0.87), P = 0.009). These results were later confirmed by
two large studies [30, 31] conducted, respectively, on 15,022
and 330 patients that both showed a mortality reduction
related to the implementation of ScvO2 as a resuscitation
goal. Though Levy’s et al. study [30] failed to show any
survival improvement specifically related to ScvO2 imple-
mentation, the global target implementation did (lactate
measure, blood culture before antibiotics, broad spectrum
antibiotics, fluid and vasopressors, CVP >8mmHg, and
ScvO2 >70%). This could be partly explained by the fact that,
among those 6 resuscitation targets, ScvO2 >70%was the less
commonly achieved, both after the first quarter of patients
was included and after the final quarter of patients was
included (resp., in 13.3% and 24.3% of the cases). Recently,
Jones et al. [32] showed, in 300 septic shock patients, that
the mortality of patients who benefited from a ScvO2 goal-
directed therapy was low (23% (17–30%)) and similar to
those who were treated using a lactate clearance goal-directed
therapy (17% (11–24%)).
ScvO2 is considered as a suitable prognosis factor inmany
clinical situations in the critically ill patients. The Surviving
Sepsis Campaign [33], gathering all European guidelines
regarding severe sepsis and sepsis shock patients manage-
ment, suggested including ScvO2 as a goal parameter in the
first 6 hours of management (ScvO2 >70%).
5. ScvO2 Limits
5.1. Theoretical Limits. The first limit of using ScvO2 refers to
its ignorance of the coronary sinus venous blood saturation.
As the extremity of the ScvO2 catheter usually stands
upstream from the joining point of coronary sinus in the
right auricle, the ScvO2 value does not take into account the
myocardial oxygen supply/demand adequacy. As myocardial
oxygen extraction is physiologically basically high, venous
coronary blood is one of the most deoxygenated venous
bloods [9] of the body. This explains that the value of mixed
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Table 1: Summary of the studies comparing SvO2 and ScvO2 in humans or in experimental models.
Author (year) Type of patients (n) Conclusion Correlation coefficient
Tahvanainen et al. [13] (1982) Intensive care (42) ScvO2 = SvO2 NC
Wendt et al. [14] (1990) Intensive care (19) ScvO2 ∼ SvO2 0,78
Kong et al. [15] (1990) Kidney failure (8) ScvO2 ∼ SvO2 NC
Berridge et al. [16] (1992) Intensive care (51) ScvO2 = SvO2 0,92
Herrera et al. [17] (1993) Thoracic surgery (23) ScvO2 = SvO2 NC
Pieri et al. [18] (1995) Major surgery (39) ScvO2 /= SvO2, nonsubstituable 0,90
Ladakis et al. [19] (2001) Intensive care (61) ScvO2 = SvO2 0,94
Reinhart et al. [11] (2004) Intensive care (32) ScvO2 ∼ SvO2 0,81
Chawla et al. [20] (2004) Intensive care (53) ScvO2 > SvO2 0.88
Dueck et al. [21] (2005) Neurosurgery (70) ScvO2 /= SvO2, substituable evolution ≥0,75
Ho et al. [22] (2010) Intensive care ScVO2 /= SvO2, nonsubstituable NC
venous blood saturation of oxygen (SvO2), which actually
takes into account venous coronary blood, is usually lower
than the ScvO2. Moreover, any major increase in myocardial
oxygen consumption could lead to a critical myocardial
oxygen extraction that would have no impact on ScvO2 mon-
itoring. Besides, ScvO2, just as SvO2, is a global oxygenation
parameter. So any local change in tissue oxygenation is at
risk of being “diluted” in the rest of venous blood and then
becoming undetectable. Similarly, in the case of a drop in
regional venous saturation responsible for a drop of ScvO2, it
would not be possible to assess the affected territory without
further exploration. Then, theoretically, the distal extremity
of the central venous catheter is supposed to be placed at the
joining point of vena cava and the right auricle to enable
a suitable assessment of tissue oxygenation of inferior and
superior territories. However, checking the position of the
catheter’s distal extremity with chest X-ray is not accurate
enough. Moreover, as venous saturation from the superior
vena cava is systematically lower than inferior vena cava,
any variation in the position of the catheter’s tip could have
a major influence on the measures and therefore lead to
ScvO2 misinterpretation. Ultimately, as previously reported,
ScvO2 depends on tissue oxygen extraction and hemoglobin
affinity for oxygen. Experiments report that septic patients
could suffer from a decrease in oxygen extraction capacity
[34, 35], a rise in capillary shunt [34], as well as changes in
hemoglobin affinity for oxygen [36]. All these changes may
alter the theoretical relationship between SvcO2, and cardiac
output, such as ScvO2 interpretation, to guide hemodynamic
therapy becomes more complex.
5.2. Clinical Limits. First of all, one could argue that ScvO2
measurement requires a central venous catheter, which is
an invasive technique, exposing patients to complications
such as infection or hemorrhage. However, central venous
lines are often needed for critically patients and could
therefore be used for ScvO2 monitoring. However, in severe
sepsis and septic shock, tissue hypoperfusion should lead
to particularly low ScvO2 values, as observed by Rivers
et al. in the early stage of sepsis. However, after the first
hours of resuscitation, this situation is rarely met [37], and
ScvO2 values tend to be paradoxically normal or even raised.
This could be explained by the physiological modification
induced by sepsis and previously described (decrease in
tissue oxygen extraction capacity, rise of capillary shunt, and
changes in hemoglobin affinity for oxygen). Consistently,
in such situations, the agreement between SvO2 and ScvO2
seems much less satisfactory, especially in the context of
septic shock [22, 38, 39]. Besides, ScvO2 clinical validation
is mainly based on one single study [29], which is a single
centre study, and its results are still controversial. As a
matter of fact, van Beest et al. [37], in a Dutch prospective
multicenter study, reported that only 1% of the patients
meeting the inclusion criteria required by Rivers et al. [29]
had a ScvO2 <50%. Ho et al. [40], in a retrospective study,
as well as the ARISE group (Australian Resuscitation of
Sepsis Evaluation), in a multicenter study [41], reported an
in-hospital mortality of 26–28% in patients who did not
benefit from an early goal-directed therapy but that met
the inclusion criteria for Rivers’ trial. This mortality rate is
much lower than the one observed by Rivers in his control
group. Finally, the low CVP values (5-6mmHg) observed by
Rivers et al. suggest that their patients were probably highly
hypovolemic.
5.3. Global versus Regional Circulation. If global hemody-
namic optimization is considered as an essential prerequisite
to ensure adequate tissue perfusion, it may not be always
sufficient to avoid the development of organ failure. The
poor accuracy for global oxygen venous saturation monitor-
ing to detect changes in regional oxygenation has been well
described in animal models [42–44]. For instance, Legrand
et al. [42] recently showed in a rat model that LPS-induced
endotoxemia could induce alterations in microvascular per-
fusion and oxygenation in the renal cortex in rats, which
appeared to be only weakly dependent on systemic and renal
macrohemodynamic alterations. Consistently, Vallet et al.
[44] and Lagoa et al. [43] reported, in endotoxemic dogs,
that after resuscitation skeletal VO2 is maintained when
blood flow within the gut is significantly disturbed with
mucosal hypoxia. In human beings, as described by Sakr et
al. [4]. global hemodynamic parameters fail to discriminate
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survivors from nonsurvivors after 24 hours of intensive care
in septic shock patients. One illustrative example is the
lack of accuracy of global SvO2 to detect cerebral venous
desaturations [45]. In this perspective, global ScvO2 might
face some limitations with respect to local inadequacy in
the DO2/VO2 balance. Indeed, local SvO2 might not be
detected by global oxygen saturation monitoring, the signal
being diluted among a global normally saturated venous
blood. Therefore, regional SvO2 could be an interesting
supplementary target parameter. However, while regional
SVO2 monitoring might be feasible at the bedside for some
organ, such as jugular venous oxygen monitoring [46–48],
it is much more difficult for others such as the kidney or
the gut, for example. In such situation, some alternative pa-
rameters for regional monitoring could be of interest.
6. Candidate Parameter to Reflect Regional
Inadequate Oxygen Supply
As for now, no biological or technical parameter has been
proved to directly reflect regional oxygen supply inadequacy.
Nevertheless, some parameters appear to be good surrogate
candidate, such as tissue oxygen saturation (StO2) and
regional carbon dioxide partial pressure (pCO2).
6.1. Tissue Oxygen Saturation (StO2). StO2 can be estimated
by near-infrared spectroscopy (NIRS) using the differen-
tial absorption properties of oxygenated and deoxygenated
hemoglobin. Near-infrared light (wave length 680–800 nm)
easily crosses biological tissue and is only absorbed by he-
moglobin, myoglobin, and oxidized cytochrome, but the
contribution of myoglobin and oxidized cytochrome in light
absorption is very low [49, 50]. Light tissue penetration is
dependant on the space between the illumination fiber and
the detection fiber. With a 25mm space, 95% of the light
signals detected come from a 0–23mm depth.
The steady StO2 value is a reflection of oxygen saturation
of the haemoglobin present in the tissue volume crossed
by the near-infrared light, containing a mix of arteriolar,
capillary, and venous blood. It is then a complicated in-
tegrative parameter, but it has been shown to be correlated
to the microcirculation state and is therefore considered as
an acceptable parameter for tissue perfusion [51].
During shock from various origins, the relationship
between StO2 values at the forearm and the prognosis has
been extensively studied during the past decade [52–55].
During shock states, as StO2 drops correlate with fall in
central venous, mixed venous oxygen saturation, or oxygen
delivery [56–59], StO2 seems to be a good marker of regional
DO2/VO2 imbalance, with the advantage of being applicable
to different regional territories such as the brain [60], the
liver [61], or the muscle [62], for example. However, this
technique suffers some limitations, the major one being
its poor sensitivity to rule out tissue hypoperfusion [55].
In order to improve its sensitivity, vascular occlusion tests
(transient upper arm arterial occlusion with a pneumatic
cuff) have been proposed [63]. By continuously monitoring
StO2 during the test, a pattern curve is obtained with an
initial decrease of StO2 during occlusion, followed after cuff
deflation by an increase of StO2 usually transiently reaching
higher values than baseline (hyperemic response) before
returning to baseline. The slope of the decreasing part of
the curve is the StO2 desaturation rate and is correlated to
the tissue oxygen consumption, whereas the slope of the
increasing part of the curve is the StO2 recovery rate and is
correlated to the quality of the microvascular bedside [64].
6.2. Carbon Dioxide Partial Pressure. Regional capnography
relies on the principle that cellular oxygen consumption
through oxidative phosphorylation produces proportional
amount of carbon dioxide. In this perspective, any decrease
in blood flow would result in a CO2 accumulation detected
by a capnograph. Tissue pCO2 could then be used as a sur-
rogate for regional blood flow and oxygen consumption
combined [65]. However, regional pCO2is difficult to inter-
pret, because CO2 production also depends on cellular
metabolism level and arterial glucose concentration. This
probably explains the fact that, despite appealing, this
parameter is still rarely used in clinical practice.
7. Conclusion
In conclusion, ScvO2 measurement seems to be an interest-
ing tool, especially in the early phase of shock to guide fluid
management and blood transfusion or inotropic support.
Nevertheless, a large knowledge of its determinants and the
physiology of circulation seem to be essential to ensure
a reliable interpretation in clinical practice. When ScvO2
is low, it reflects an adaptive mechanism to an unsuitable
supply in oxygen and should lead doctors to understand the
reasons for it and to propose an appropriate optimization
strategy. As well, in clinical situations such as septic shock,
after the first hours of management, a “normal” or even a
high ScvO2 can be falsely reassuring.
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